Cargando…
The Evolving Story of Multifactorial Chylomicronemia Syndrome
Multifactorial chylomicronemia syndrome (MCS or type V hyperlipoproteinemia) is the most frequent cause of severe hypertriglyceridemia and is associated with an increased risk of acute pancreatitis, cardiovascular disease, and non-alcoholic steatohepatitis. The estimated prevalence of MCS in the Nor...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046927/ https://www.ncbi.nlm.nih.gov/pubmed/35498015 http://dx.doi.org/10.3389/fcvm.2022.886266 |
_version_ | 1784695622855557120 |
---|---|
author | Paquette, Martine Bernard, Sophie |
author_facet | Paquette, Martine Bernard, Sophie |
author_sort | Paquette, Martine |
collection | PubMed |
description | Multifactorial chylomicronemia syndrome (MCS or type V hyperlipoproteinemia) is the most frequent cause of severe hypertriglyceridemia and is associated with an increased risk of acute pancreatitis, cardiovascular disease, and non-alcoholic steatohepatitis. The estimated prevalence of MCS in the North American population is 1:600–1:250 and is increasing due to the increasing prevalence of obesity, metabolic syndrome, and type 2 diabetes. Differentiating between familial chylomicronemia syndrome and MCS is crucial due to their very different treatments. In recent years, several cohort studies have helped to differentiate these two conditions, and recent evidence suggests that MCS itself is a heterogeneous condition. This mini-review will summarize recent literature on MCS, with a specific focus on the genetic determinants of the metabolic risk and the latest developments concerning the pharmacological and non-pharmacological treatment options for these patients. Possible research directions in this field will also be discussed. |
format | Online Article Text |
id | pubmed-9046927 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90469272022-04-29 The Evolving Story of Multifactorial Chylomicronemia Syndrome Paquette, Martine Bernard, Sophie Front Cardiovasc Med Cardiovascular Medicine Multifactorial chylomicronemia syndrome (MCS or type V hyperlipoproteinemia) is the most frequent cause of severe hypertriglyceridemia and is associated with an increased risk of acute pancreatitis, cardiovascular disease, and non-alcoholic steatohepatitis. The estimated prevalence of MCS in the North American population is 1:600–1:250 and is increasing due to the increasing prevalence of obesity, metabolic syndrome, and type 2 diabetes. Differentiating between familial chylomicronemia syndrome and MCS is crucial due to their very different treatments. In recent years, several cohort studies have helped to differentiate these two conditions, and recent evidence suggests that MCS itself is a heterogeneous condition. This mini-review will summarize recent literature on MCS, with a specific focus on the genetic determinants of the metabolic risk and the latest developments concerning the pharmacological and non-pharmacological treatment options for these patients. Possible research directions in this field will also be discussed. Frontiers Media S.A. 2022-04-14 /pmc/articles/PMC9046927/ /pubmed/35498015 http://dx.doi.org/10.3389/fcvm.2022.886266 Text en Copyright © 2022 Paquette and Bernard. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Paquette, Martine Bernard, Sophie The Evolving Story of Multifactorial Chylomicronemia Syndrome |
title | The Evolving Story of Multifactorial Chylomicronemia Syndrome |
title_full | The Evolving Story of Multifactorial Chylomicronemia Syndrome |
title_fullStr | The Evolving Story of Multifactorial Chylomicronemia Syndrome |
title_full_unstemmed | The Evolving Story of Multifactorial Chylomicronemia Syndrome |
title_short | The Evolving Story of Multifactorial Chylomicronemia Syndrome |
title_sort | evolving story of multifactorial chylomicronemia syndrome |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046927/ https://www.ncbi.nlm.nih.gov/pubmed/35498015 http://dx.doi.org/10.3389/fcvm.2022.886266 |
work_keys_str_mv | AT paquettemartine theevolvingstoryofmultifactorialchylomicronemiasyndrome AT bernardsophie theevolvingstoryofmultifactorialchylomicronemiasyndrome AT paquettemartine evolvingstoryofmultifactorialchylomicronemiasyndrome AT bernardsophie evolvingstoryofmultifactorialchylomicronemiasyndrome |